Header Logo

Connection

JOHN BELMONT to Cytopathogenic Effect, Viral

Back to Details
This is a "connection" page, showing publications JOHN BELMONT has written about Cytopathogenic Effect, Viral.
JOHN BELMONT
Connection Strength
0.069
Cytopathogenic Effect, Viral
  1. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene. Hum Gene Ther. 1997 May 01; 8(7):861-8.
    View in: PubMed
    Score: 0.037
  2. Inhibition of HIV-1 by a double transdominant fusion gene. Gene Ther. 1995 May; 2(3):181-6.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.